|
Match
|
Document |
Document Title |
|
|
7615650 |
Process for producing chroman compound
The invention provides a process for producing a chroman compound represented by formula (1), characterized in that the process includes allowing a phenol, an unsaturated compound, and a...
|
|
|
7560575 |
Process for preparation of racemic Nebivolol
A process of making racemic [2S*[R*[R*[R*]]]] and [2R*[S*[S*[S*]]]]-(±)α,α′-[iminobis(methylene)]bis[6-fl
uoro-3,4-dihydro-2H-1-benzopyran-2-methanol] of the compound of the formula (I)
...
|
|
|
7528267 |
Method for enantioselective hydrogenation of chromenes
A method for preparing an enantiomeric chromane, by asymmetrically hydrogenating a chromene compound in the presence of an Ir catalyst having a chiral ligand. The method includes the...
|
|
|
7429411 |
Chroman compound, liquid crystal composition including the compound and liquid crystal display element including the liquid crystal composition
The compound (1) according to the invention has general solid-state properties necessary for a compound, stability against heat, light and the like, a suitable optical anisotropy, a suitable...
|
|
|
7427693 |
Polar liquid crystal
Compounds that are useful in compositions for flat panel displays, for example, are provided. The compounds provided are polar, and are useful in low threshold voltage mixtures. The compounds...
|
|
|
7410998 |
Inhibitors of NADH:ubiquinone oxidoreductase
Benzopyran-based inhibitors of NADH:ubiquinone oxidoreductase for inhibiting the growth of cancer cells.
|
|
|
7384976 |
Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use
The invention describes novel compositions comprising nebivolol and/or at least one metabolite of nebivolol and at least one nitric oxide donor, and, optionally, at least one antioxidant or a...
|
|
|
7365095 |
Chromane and chromene derivatives and uses thereof
Compounds of formula I or pharmaceutically acceptable salts thereof are provided:
wherein each of R 1 , R 2 , R 3 , R 4 , y, m, n, and Ar are as defined, and described in classes and subclasses...
|
|
|
7312232 |
Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
The present invention provides an antiproliferative compound having the structural formula
wherein X is oxygen, nitrogen or sulfur; Y is selected from the group consisting of oxygen, nitrogen...
|
|
|
7297715 |
PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
A class of chromane and chromene compounds having the structure shown below and pharmaceutically acceptable salts thereof are useful as therapeutic compounds, particularly in the treatment and...
|
|
|
7217706 |
Propanolamine derivatives
This invention relates to new propanolamine derivatives or salts thereof represented by the following formula [I]:
Wherein each symbol is as defined in the specification or salts thereof which...
|
|
|
7148240 |
Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
The invention relates to benzofuran or benzothiophene derivatives of general formula:
These compounds are of use as medicinal products, in particular in the treatment of pathological syndromes...
|
|
|
7144919 |
Polyoxyethylene-polyoxypropylene vitamin E and process for preparation thereof
The present invention relates to polyoxyethylene-polyoxypropylene (POE-POP) vitamin E, which is prepared from vitamin E by polyethoxylation and polypropoxylation, and a method for preparing the...
|
|
|
7138430 |
Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
The invention describes novel nitrosated and/or nitrosylated nebivolol, novel nitrosated and/or nitrosylated metabolites of nebivolol and novel compositions comprising at least one nitrosated...
|
|
|
7045514 |
Therapeutic heterocyclic compounds
Provided herein is a compound having the formula (I):
Wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety,...
|
|
|
6890952 |
Cyclic substituted aminomethyl compounds and medicaments comprising these compounds
Cyclic substituted aminomethyl compounds of general formula IA and IB, methods for production thereof, intermediates in said production methods, a medicament containing at least one of said cyclic...
|
|
|
6855833 |
Methods for producing amino substituted chromanes and intermediates thereof
Disclosed are processes for producing chromane compounds, preferably chroman-2-yl acetic acid compounds and 6-amino-chroman-2-yl acetic acid esters which are intermediates for producing platelet...
|
|
|
6835845 |
Methine compound, material for organic luminescence element, and organic luminescence element using the same
A is a novel methine compound, for example, which is represented by the following formula (I): wherein R 1 , R 2 , R 3 , R 4 and R 5 each represents a hydrogen atom or a substituent; X...
|
|
|
6818666 |
Bi-aromatic compounds linked via a heteroethylene radical, and pharmaceutical and cosmetic compositions using them
Bi-aromatic compounds linked via a heteroethynylene radical are provided along with pharmaceutical and cosmetic compositions containing these compounds and methods for their use.
|
|
|
6750247 |
Sponge-derived terpenoids and methods of use
Compounds that are effective lipoxygenase inhibitors, and methods and pharmaceutical compositions for inhibiting lipoxygenases and for treatment of lipoxygenase-mediated conditions in humans and...
|
|
|
6716873 |
Tocopherol ester compounds
Disclosed are novel tocopherol ester compounds having the formula wherein X is a chain of 2 or 3 carbon atoms, e.g., ethylene and trimethylene, joining the 2 carbonyl groups to which they are...
|
|
|
6700001 |
Process for stereoselective synthesis of 2-hydroxymethyl chromans
A process for the stereoselective synthesis of 2-hydroxymethyl-chromans of formula (II) is provided where R, R 1 , R 2 and R 3 are as defined herein. The compound of formula (II) is prepared...
|
|
|
6699860 |
Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists
This invention is related to novel di-substituted aminomethyl chroman derivatives which are useful in the treatment of beta-3 receptor-mediated conditions.
|
|
|
6660871 |
Synthesis of 4H-chromene derivatives
Substituted 4H-chromene derivatives are a new class of compounds that bind to Bcl-2 protein and induce apoptosis in tumor cells. The present invention is directed to an efficient synthetic method...
|
|
|
6653488 |
Process for producing benzopyran carboxamide
A first process for producing a benzopyran carboxamide represented by the general formula [1] includes reacting 3-aminopropionitrile.½ sulfate, N≡CCH 2 CH 2 NH 2 .½(H 2 SO 4 ), with a...
|
|
|
6653472 |
Preparing amidines derived from 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid
New intermediates of the formula (II)B described below for the synthesis of amidine derivatives of (−)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid, such as for example...
|
|
|
6646136 |
Chroman derivatives
Chroman derivatives of the formula I in which R 1 is acyl having 1-6 C atoms, —CO—R 5 or an amino protective group, R 2 is H or alkyl having 1-6 C atoms, R 3 , R 4 in each case...
|
|
|
6638972 |
Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
|
|
|
6638970 |
Substituted alkylene diamine compounds
Novel compounds of the general formula: and pharmaceutically acceptable acid addition salts thereof, wherein the compounds are useful in therapy to protect skeletal muscles against damage...
|
|
|
6635650 |
Substituted dimeric compounds
The invention relates to compounds of formula (I): A-G 1 -Cy-G 2 -Cy-G 3 -B (I) wherein: A represents NR 1 C(Q)R 2 , C(Q)NR 2 R 3 or NR 1 C(Q)NR 2 R 3 , B represents NR 1 C(Q)R 2 , C(Q)NR 2 R 3...
|
|
|
6620947 |
Compounds for use in 11-oxa prostaglandin synthesis
Novel processes and intermediates useful in the preparation of 11-oxa prostaglandin analogs are disclosed.
|
|
|
6599933 |
Tocotrienol derivative, process for producing the same and &ggr -CEHC delivering agent
The object of the present invention is to provide a tocotrienol derivative which is highly water-soluble and shows high bioavailability in the living body and γ-CEHC delivering agent. (A...
|
|
|
6518264 |
Azetidine derivatives, their preparation and medicaments containing them
Disclosed are azetidine derivatives of formula: their optical isomers, their salts, their preparation and medicaments containing them.
|
|
|
6482950 |
Squarylium compounds, and processes and intermediates for the synthesis of these compounds
Squarylium compounds of the formula: wherein Q 1 and Q 2 are each independently a pyrylium, thiopyrylium, selenopyrylium, benzpyrylium, benzthiopyrylium or benzselenopyrylium nucleus, and R 1 ...
|
|
|
6479670 |
Selective retinoid acid receptor agonists
This invention relates to new selective retinoid acid receptor agonists of formula I wherein the symbols are as defined in the specification to their pharmaceutically acceptable salts,...
|
|
|
6479540 |
Compositions of tocol-soluble therapeutics
Tocol-based compositions of charged amphiphilic and water soluble pharmaceutically active compounds or their charged precursors are prepared by forming a tocol-soluble ion pair with an oppositely...
|
|
|
6429320 |
Processes for the purification of tocopherol and/or sterol compounds and compositions containing orthoborate ester mixtures
Processes for purifying compounds are disclosed which include reacting (i) a mixture of at least one tocopherol compound or sterol compound, and an alcohol having from about 10 to 30 carbons with...
|
|
|
6403638 |
2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
Compounds having the formulas below, where R is H, lower alkyl, or a pharmaceutically acceptable salt, and where R 1 represents i-propyl, t-butyl or n-butyl groups, have selective RXR retionoid...
|
|
|
6369099 |
Method of locking 1 α-OH of vitamin D compounds in axial orientation
A method of modifying or altering the structure of a 1α-hydroxylated vitamin D compound to increase its biological activity by altering the conformational equilibrium of the A-ring to favor a...
|
|
|
6358995 |
Carboxylic acid derivatives having fused rings
The present invention provides a medicament exhibiting excellent retinoic acid receptor agonism. A Carboxylic acid derivative having a fused ring which is represented by the following formula or a...
|
|
|
6350453 |
Tocotrienols and geranylgeraniol from Bixa orellana byproducts
A source of material known as a byproduct solution of Bixa orellana seed components, which is obtained as an oily material after the bulk of annatto color, is removed from either the aqueous...
|
|
|
6348605 |
Process for preparing 3-hydroxymethyl chromen-4-ones
3-(Hydroxymethyl)chromen-4-ones of formula (I) are described and a process for preparing said compounds. The process consists in reacting the compounds of general formula (II) wherein R is...
|
|
|
6313160 |
Substituted heterocyclic compounds, method for preparing and compositions containing same
The invention relates to compounds of formula (I): ##STR1## wherein: R 1 , R 2 and R 3 are as defined in the description, X is as defined in the description, Y represents an oxygen atom,...
|
|
|
6310074 |
Substituted dimeric compounds
The invention relates to compound of formula (I): A--G 1 --Cy--G 2 --Cy'--G 3 --B (I) wherein: A represents a grouping NR 1 C(Q)R 2 , C(Q)NR 2 R 3 or NR 1 C(Q)NR 2 R 3 , B...
|
|
|
6297273 |
Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
Disclosed and claimed are cocoa extracts, compounds, combinations thereof and compositions containing the same, such as polyphenols or procyanidins, methods for preparing such extracts, compounds...
|
|
|
6288071 |
1-ethylene-2-alkylene-1,4-cyclohexadiene pesticides
Pesticidally active cyclohexadienyl derivative compounds of the formula I that are esters, oximes or amides are claimed. These compounds may be used as fungicides, acaricides and insecticides in...
|
|
|
6281240 |
Diarylsulfonylureas for use in treating secretory diarrhea
This invention provides methods of treating secretory diarrhea or cystic fibrosis in a mammal which comprises administering to a mammal in need thereof an effective amount of diarylsulfonylurea....
|
|
|
6136986 |
Process for preparing substituted chroman derivatives
The invention relates to a process for preparing substituted chroman derivatives of the general formula VII, ##STR1## where X is the group --CN, --COOR 3 , --CHO, --CH 2 OR 7 or --CH(OR 8 ) 2 , ...
|
|
|
6136985 |
CLA esters and uses thereof
The present invention provides CLA esters and uses thereof. More particularly, the present invention provides a composition for topical use comprising CLA esters and a topical carrier. In addition,...
|
|
|
6124347 |
Chromene derivatives and salts thereof, and pharmaceuticals containing the same
Disclosed are chromene derivatives represented by the following formula: ##STR1## wherein R 1 s represent alkyl, alkoxy or like groups, R 2 represents a hydrogen atom or an alkyl group, R 3 ...
|